OraSure Technologies to Present at the Stephens Annual Investment Conference 2020
OraSure Technologies (NASDAQ: OSUR) announced that Dr. Stephen S. Tang, President and CEO, will present at the Stephens Annual Investment Conference 2020 on November 19, 2020, at 8:00 AM EST. The event will be webcast live, allowing investors to tune in via OraSure’s website. A replay will be available for seven days post-event. OraSure Technologies specializes in point-of-care diagnostics and specimen collection, striving to enhance global health with innovative solutions.
- None.
- None.
BETHLEHEM, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Stephens Annual Investment Conference 2020. The conference will be simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on November 19, 2020, at approximately 8:00 AM Eastern Standard Time (5:00 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: https://kvgo.com/stephens/orasure-november-2020
About OraSure Technologies
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, CoreBiome (now operating under the Diversigen brand), UrSure and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, commercial entities and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.
Company contacts:
Sam Martin
Argot Partners
212-600-1902
OraSure@argotpartners.com
Jeanne Mell
VP Corporate Communications
484-353-1575
media@orasure.com
www.orasure.com
FAQ
What is the date and time of the OraSure Technologies presentation at the Stephens Annual Investment Conference 2020?
How can I access the live webcast of OraSure Technologies' conference presentation?
Will there be a replay available for the OraSure Technologies presentation?
Who is the speaker for OraSure Technologies at the Stephens Annual Investment Conference 2020?
What is the stock symbol for OraSure Technologies?
